TNDM Stock Likely to Gain From Innovation Amid Competition
Tandem Diabetes is driving transformative innovation to help reduce the burden of diabetes and create new possibilities for ...
DexCom: Investors Discounting Long CGM Growth Runway
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, ...
Sugar High: How a Glucose Monitor Told Me Startling Things About My Diet
Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...
Researchers present ranges of normal glucose levels among non-diabetic adults wearing continuous glucose monitors
New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...
BioWorld5d
FDA clears Senseonic’s Eversense one-year implantable CGM
The U.S. FDA cleared Senseonic Holdings Inc.’s Eversense 365, the first continuous glucose monitor to last a full year with a single sensor rather than the 10 days to two weeks typical for wearable ...
Le Lézard2h
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time ... STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and ...
medtechdive3d
Abbott debuts Lingo over-the-counter CGM in the US
Abbott rolled out its first over-the-counter glucose sensor in the U.S. on Thursday, just over one week after Dexcom began selling its competing product. The device, called Lingo, is intended to be ...
drugdeliverybusiness5d
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
Armed robbery in Revesby5d
Research Reveals Normal Glucose Ranges in Non-Diabetics
"Many individuals without diabetes are becoming interested in using continuous glucose monitors and two major manufacturers ...
Senseonics Holdings, Inc.: Eversense 365 Receives FDA Clearance: The World's First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...